Quality of Chronic Anticoagulation Control in Patients with Intracranial Haemorrhage due to Vitamin K Antagonists

Table 1

Baseline characteristics.

BASELINE CHARACTERISTICS (N=53)
Age, median (range) years	79 (56-93)
Sex (female)	26 (42%)
Previous mRS N (%)
(i) 0-3	41 (91%)
(ii) 4-5	4 (9%)
Arterial hypertension N (%)	4 (9%)
Diabetes mellitus N (%)	13 (25%)
Dyslipidemia N (%)	23 (43%)
Previous stroke:
(i) TIA N (%)	7 (13.21%)
(ii) Ischaemic N (%)	2 (5%)
(iii) Haemorrhagic N (%)	3 (6.5%)
(iv) Both N (%)	2 (5%)
HASBLED median (p25-p75)	2.5 (2-3)
CHAD2S2-VASc median (p25-p75)	4 (3-5)
Condition requiring anticoagulation:
(i) Atrial fibrillation N (%)	48 (90.6%)
(ii) Mechanical heart valves N (%)	5 (9.4%)
Concomitant medications:
(i) Antiplatelet agents N (%)	3 (6.5%)
(ii) Statins N (%)	19 (43.2%)
Leukoaraiosis N (%)	24 (47%)

TIA: transient ischaemic attack. VKA: vitamin K antagonist.